Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis
Background Anticardiolipin antibodies of the immunoglobulin G isotype (IgG aCL) have
been suggested as risk factor for arterial and venous thrombosis. No conclusive data in …
been suggested as risk factor for arterial and venous thrombosis. No conclusive data in …
Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients
A Bili, AJ Moss, CW Francis, W Zareba, LFM Watelet… - Circulation, 2000 - Am Heart Assoc
Background—The association of anticardiolipin (aCL) antibodies with coronary artery
disease has been shown in several studies but remains controversial. We evaluated the …
disease has been shown in several studies but remains controversial. We evaluated the …
Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease
F Puisieux, P de Groote, E Masy, C Di Pompeo… - The American journal of …, 2000 - Elsevier
PURPOSE: Anticardiolipin antibodies may be associated with recurrent thromboembolic
events in patients with myocardial infarction or stroke. We sought to determine the …
events in patients with myocardial infarction or stroke. We sought to determine the …
Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Vasterbotten cohort project
E Ahmed, B Stegmayr, J Trifunovic, L Weinehall… - Stroke, 2000 - Am Heart Assoc
Background and Purpose—Anticardiolipin antibodies (aCL) have been proposed to be an
independent risk factor for stroke. To test this hypothesis, a nested case-control study was …
independent risk factor for stroke. To test this hypothesis, a nested case-control study was …
Anticardiolipin antibodies and their associations with cerebrovascular risk factors
D Tanne, L D'Olhaberriague, LR Schultz… - Neurology, 1999 - AAN Enterprises
Objective: To investigate associations between cerebrovascular risk factors and
anticardiolipin (aCL) immunoreactivity. Background: High titers of aCL immunoreactivity …
anticardiolipin (aCL) immunoreactivity. Background: High titers of aCL immunoreactivity …
The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-β2-glycoprotein I antibodies
C Neville, J Rauch, J Kassis, S Solymoss… - …, 2006 - academic.oup.com
Objective. We studied antiphospholipid antibodies (aPL) in blood samples from a cohort of
individuals followed for thrombosis to determine whether the persistent presence of …
individuals followed for thrombosis to determine whether the persistent presence of …
Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies
S Sairam, BA Baethge, T McNearney - Clinical rheumatology, 2003 - Springer
Our objective was to identify the role of various disease states and additional risk factors in
the development of thrombosis in patients with anticardiolipin antibodies (aCL). We …
the development of thrombosis in patients with anticardiolipin antibodies (aCL). We …
IgG anticardiolipin antibody titer> 40 GPL and the risk of subsequent thrombo-occlusive events and death: a prospective cohort study
SR Levine, L Salowich-Palm, KL Sawaya, M Perry… - Stroke, 1997 - Am Heart Assoc
Background Anticardiolipin antibodies (aCL) have been associated with an increased risk of
stroke and thrombo-occlusive events. Little is known about the influence of aCL on recurrent …
stroke and thrombo-occlusive events. Little is known about the influence of aCL on recurrent …
β2-Glycoprotein 1–Dependent Anticardiolipin Antibodies and Risk of Ischemic Stroke and Myocardial Infarction: The Honolulu Heart Program
RL Brey, RD Abbott, JD Curb, DS Sharp, GW Ross… - Stroke, 2001 - Am Heart Assoc
Background—It has been hypothesized that immunoreactivity to β2-glycoprotein 1 (β2GP1)-
dependent anticardiolipin antibody (aCL), but not β2GP1-independent aCL, is associated …
dependent anticardiolipin antibody (aCL), but not β2GP1-independent aCL, is associated …
Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men
O Vaarala, M Mänttäri, V Manninen, L Tenkanen… - Circulation, 1995 - Am Heart Assoc
Background Data concerning the relation between anti-phospholipid (aPL) antibodies and
myocardial infarction in subjects without evidence of overt autoimmune disease are …
myocardial infarction in subjects without evidence of overt autoimmune disease are …
相关搜索
- recurrent cardiovascular events
- anticardiolipin antibodies meta regression
- immunoglobulin g igg
- anticardiolipin antibodies risk factors
- anticardiolipin antibodies thrombosis in patients
- anticardiolipin antibodies comorbid diseases
- anticardiolipin antibodies lupus anticoagulant
- risk factors thrombosis in patients
- anticardiolipin antibodies cohort project
- risk factors comorbid diseases
- lupus anticoagulant increased risk
- risk factor cohort project
- events and death antibody titer
- anticardiolipin antibodies increased risk
- anticardiolipin antibodies development of thrombosis
- anticardiolipin antibodies mortality in patients